NCT06261866

Brief Summary

The aim of this prospective, investigator-initiated study is to evaluate the diagnostic accuracy and correlations between functional indices (fractional flow reserve, FFR) and morphometric indices: luminal and qualitative parameters assessed by optical coherence tomography (OCT) including minimal lumen area, plaque type, presence of thin cap fibroatheroma among patients with chronic coronary syndrome identified with intermediate grade coronary stenosis.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
29mo left

Started Apr 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Apr 2011Dec 2028

Study Start

First participant enrolled

April 7, 2011

Completed
12.8 years until next milestone

First Submitted

Initial submission to the registry

February 7, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 15, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Expected
Last Updated

February 15, 2024

Status Verified

February 1, 2024

Enrollment Period

13.7 years

First QC Date

February 7, 2024

Last Update Submit

February 7, 2024

Conditions

Keywords

FFROCTIVUSCCS

Outcome Measures

Primary Outcomes (2)

  • Correlation between fractional flow reserve (FFR) and minimal lumen area within the coronary stenosis

    Baseline

  • Correlation between fractional flow reserve (FFR) and mean lumen area within the coronary stenosis

    Baseline

Secondary Outcomes (1)

  • Major adverse cardiovascular events

    36 months

Study Arms (1)

Patients with chronic coronary syndromes identified with intermediate grade coronary stenosis

Patients chronic coronary syndrome identified with intermediate grade coronary stenosis undergo coronary angiography according to current practice and guidelines recommendations. FFR will be measured, in consistency with the guidelines and recommended clinical practice. In case of FFR \> 0.8 optimal pharmacotherapy will be prescribed; on the contrary, in case of FFR ≤ 0.8 PCI will be performed. OCT imaging will be performed with commercially available device (Abbott, C7XR Dragonfly TM LightLab Imaging Inc., MA, USA) using the non-occlusive flushing technique.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients undergoing coronary angiogram due to chronic coronary syndrome with intermediate grade coronary stenosis.

You may qualify if:

  • years or older
  • Chronic coronary syndrome defined as presence of chest pain ranked 2-3 in the Canadian Cardiovascular Society classification or positive ischemia test (exercise test, single photon emission tomography (SPECT)
  • Intermediate grade coronary stenosis of 40-80% assessed visually in coronary angiography
  • FFR and OCT examination of the same lesion
  • The patient is willing to participate in the study and has provided a written informed consent

You may not qualify if:

  • Acute coronary syndrome
  • Proximal left main lesion
  • Ostial right coronary artery lesion
  • Bypass of the assessed vessel
  • Contraindications for adenosine administration
  • Hemodynamic instability
  • Heart insufficiency in New York Heart Association (NYHA) class IV scale
  • Acute renal insufficiency
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Warsaw

Warsaw, Poland

RECRUITING

Study Officials

  • Mariusz Tomaniak, MD, PhD, Assoc. Prof.

    Medical University of Warsaw

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mariusz Tomaniak

CONTACT

Piotr Baruś

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD, FESC

Study Record Dates

First Submitted

February 7, 2024

First Posted

February 15, 2024

Study Start

April 7, 2011

Primary Completion

December 31, 2024

Study Completion (Estimated)

December 31, 2028

Last Updated

February 15, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations